Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effect

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 415-418

  Boswell, F J ^a   Andrews, J M ^a   Wise, R ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; FROPENEM;

ARTICLE; BACTEROIDES FRAGILIS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NONHUMAN; PHARMACODYNAMICS; POSTANTIBIOTIC EFFECT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTEROIDES FRAGILIS; BETA-LACTAMS; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; KINETICS; LACTAMS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TIME FACTORS;

EID: 0030908925     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.415     Document Type: Article

References (10)

1. Wise, R. & Ballard, R. C. (1989). Review of the in-vitro evaluation of FCE 22101. Journal of Antimicrobial Chemotherapy 23, Suppl. C, 7-16.
2. Goto, S., Miyazaki, S., Ohno, A. & Nasu, T. (1991). Antibacterial activity of SY5555, a novel oral penem. In Program and Abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1991. Abstract 821, p. 236. American Society for Microbiology, Washington, DC.
3. Morosini, M. I., Negri, M. C., Loza, E. & Baquero, F. (1995). In vitro-activity of RU 67655, new oral penem antibiotic against Streptococcus pneumoniae. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F130, p. 135. American Society for Microbiology, Washington, DC.
4. Inoue, E. & Mitsuhashi, S. (1992). Antibacterial activity and βlactamases stability of SY5555, a novel oral penem. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, 1992. Abstract 391, p. 176. American Society for Microbiology, Washington, DC.
5. Craig, W. A. & Gudmundsson, S. (1991). Postantibiotic effect. In Antibiotics in Laboratory Medicine, 3rd edn (Lorian, V., Ed.), pp. 403-31. Williams & Wilkins, Baltimore, MD.
6. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). A guide to sensitivity testing. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 22-30.
7. Miles, A. A., Misra, S. S. & Irwin, J. O. (1938). The estimation of the bactericidal power of the blood. Journal of Hygiene 38, 732-49.
8. National Committee for Clinical Laboratory Standards. (1992). Methods for Determining Bactericidal Activity of Antimicrobial Agents; Tentative Guideline M26-T. NCCLS, Villanova, PA.
9. Dornbusch, K., Kronvall, G., Göransson, E. & Mörtsell, E. (1989) In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of β-lactamases. Journal of Antimicrobial Chemotherapy 23, Suppl. C, 31-41.
10. Bergholm, A. M. & Dornbusch, K. (1988). The postantibiotic effect of the new penem FCE 22101 on Gram-positive and negative bacteria in vitro and in vivo. In Proceedings of the Sixth Mediterranean Congress of Chemotherapy, Taormina, Sicily, 1988. Abstract 261.